EN
HI

Beta Drugs Share price

BETA

HealthcareSmall

1884.45

7.95 (0.42%)
NSE
BSE
Last updated on 30 May, 2025 | 15:30 IST
BUYSELL
Today's High

1897.40

Today's Low

1860.00

52 Week Low

1100.00

52 Week High

2326.00

The current prices are delayed, login to your account for live prices

Beta Drugs Chart

Beta Drugs Share Key Metrics

Volume
4515.00
Market Cap
1902.27 CR
LTQ@LTP
210@1884.45
ATP
1880.48
Var Margin
53.5 %
Circuit Range
1501.2-2251.8
Delivery %
73.58 %
Value
84.90 L
ASM/GSM
No
Market Lot
105

Beta Drugs Futures & Options

Data Not Found

Beta Drugs Corporate Actions

DateAgenda
2025-05-15Audited Results
2025-03-27Others
2025-03-26-
2025-02-05Issue of Bonus & Others
DateEvent TypeAgenda
2025-05-15Board MeetingAudited Results
2025-03-27Board MeetingOthers
2025-03-26Bonus-
2025-02-05Board MeetingIssue of Bonus & Others

Beta Drugs News

Beta Drugs raises Rs 117 crore from HealthQuad

Nov 28 2024 05:41:53
Read More

About Beta Drugs

NSE : 81  
BSE : 203739  
ISIN : INE351Y01019  

The Company was incorporated as ?Beta Drugs Private limited? at Himachal Pradesh as a private limited company under the provisions of the Companies Act 1956 vide Certificate of Incorporation dated September 21 2005 bearing Corporate Identification Number U24230HP2005PTC28969 issued by Registrar of Companies Punjab Himachal Pradesh and Chandigarh. Subsequently the Company was converted in to public limited company pursuant to Shareholders Resolution passed at the Extra-Ordinary General Meeting of the Company held on July 24 2017 and the name of the Company was changed to ?Beta Drugs Limited? pursuant to issuance of fresh Certificate of Incorporation consequent upon conversion of Company from Private to Public Limited dated August 11 2017 issued by the Registrar of Companies Himachal Pradesh. The Corporate Identification Number of the Company is U24230HP2005PLC028969.KEY EVENTS AND MILESTONES IN THE HISTORY OF THE COMPANY2005 -Incorporation of the Company as Beta Drugs Private Limited2014 -Vijay Kumar Batra existing promoter took over the Company2015-ISO: 9001:2008 Certification for manufacturing and supply of Pharmaceutical products such as Oncology  Sterile Injections and Lyophilized Injections and Oncology solid oral medication tablets and capsules-Certificate of Good Manufacturing Practice from Health and Family Welfare Department Himachal Pradesh2016-Certificate of Good Manufacturing Practice from Republic of Kenya2017 -Conversion of Company into Public Limited Company

Beta Drugs Management

NamePosition
Mr. Rahul Batra Chairperson & Managing Director
Mr. Varun Batra Joint Managing Director
Mrs. Seema Chopra Whole Time Director
Mr. Balwant Singh Whole Time Director
Mr. Manmohan Khanna Independent Director
Read More

Beta Drugs FAQs

The Buying Price of Beta Drugs share is 1884.45 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Beta Drugs share log in to your Choice trading account, or open a Choice Demat account, then add funds, search the company name, select your order type, and place your trade.

The Price-to-earnings (P/E) ratio of Beta Drugs shares is 44.84. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Beta Drugs shares is 9.65. Useful to assess the stock's value relative to its book value.

To assess Beta Drugs’s valuation compare Sector P/E, P/B which are 37.02 & 3.95 with sector averages, along with growth rates and financial metrics.

The Market Cap of Beta Drugs is 1902.27 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Beta Drugs share price is 2326.00 & 1100.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.